Baricitinib for COVID-19: a suitable treatment?
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference5 articles.
1. COVID-19: combining antiviral and anti-inflammatory treatments;Stebbing;Lancet Infect Dis,2020
2. Viral inhibition of the IFN-induced JAK/STAT signalling pathway: development of live attenuated vaccines by mutation of viral-encoded IFN-antagonists;Fleming;Vaccines (Basel),2016
3. Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment;Smolen;J Rheumatol,2019
4. Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis;Biggioggero;Drugs Context,2019
5. How to approach and treat viral infections in ICU patients;Kelesidis;BMC Infect Dis,2014
Cited by 204 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance;Drug Safety;2024-04-12
2. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals;Vaccine;2024-04
3. Audiovestibular adverse events following COVID-19 vaccinations;Vaccine;2024-03
4. Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study;PLOS ONE;2024-01-19
5. Explainable Medical AI: An Assessment of Developments;Handbook of the Philosophy of Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3